CTBRI

Unit Head

Associate Professor Rod Dawson

MBChB (Stell), FCP (SA), Cert. Pulm (SA)

Associate Professor Rod Dawson established the Centre for Tuberculosis Research Innovation at the University of Cape Town Lung Institute in 2007. He is a qualified Consultant Pulmonologist and has a special interest in chest radiology, tuberculosis and HIV infection. Associate Professor Rod Dawson was appointed Director of the University of Cape Town Lung Institute in 2016.


Centre for TB Research Innovation (CTBRI)

The mandate of the UCT Lung Institute is to address priority health issues through, education, research and service. Since 2008 CTBRI has conducted research into tuberculosis with focus areas of TB drug development, HIV/TB interaction, effects of smoking in TB and HIV and understanding adherence to medication in drug-resistant TB.

“Worldwide incidence of tuberculosis in 2015: 10,4 million cases”
“Worldwide 1,4 million deaths from tuberculosis”
“60% of deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa”

RELEVANCE

Advancing new treatment solutions for tuberculosis and HIV

EXCELLENCE

Setting the standard for clinical trials

RESPECT

Transforming life for our patients
The 2016 WHO Global Tuberculosis Report estimates that in 2015 there were 10,4 million cases of tuberculosis worldwide. Tuberculosis remains a top 10 cause of death with more than 1.4 milliion people dying annually. 60% of these deaths occur in only 6 countries: Malaysia, India, China, Nigeria, Pakistan and South Africa. TB is the principal cause of death in South Africa.

CTBRI news

3rd Jun 2019

Qurient Announces Positive Phase 2a Data of Novel Antibiotic for the Treatment of Tuberculosis

  June 03, 2019 09:00 AM Eastern Daylight Time   SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early […]
23rd Apr 2019

UCT Lung Institute World TB Day Events 2019